David T Rubin

101PUBLICATIONS
224CO-AUTHORS
Major global burdens of diseaseEvolutionary computationHealth counsellingMedical biochemistry - proteins and peptides (incl. medical proteomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (101)

|Jul 28, 2026
Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments.

|Jul 17, 2026
Artificial intelligence assessment of endoscopic severity and extent: A machine learning approach to continuous evaluation of endoscopic inflammation in ulcerative colitis.

|Jul 10, 2026
Healthcare professionals' knowledge, attitudes, and practice with addressing sexual health among people living with inflammatory bowel disease: A UK cross-sectional survey.

|Jun 26, 2026
Combined bowel urgency, clinical outcomes, and quality of life improvement in mirikizumab-treated ulcerative colitis: a step toward comprehensive disease management.

|Jun 22, 2026
Dual-targeted therapy with risankizumab and upadacitinib in medically complex Crohn's disease.

|Jun 09, 2026
Impact of Upadacitinib on Cardiovascular Events and Lipid Values in Older Inflammatory Bowel Disease Patients With Baseline Cardiovascular Risk.

Pageof 17

Frequent Collaborators

9 joint publications

Silvio Danese

6 joint publications

Siew C Ng

6 joint publications

Laurent Peyrin-Biroulet

5 joint publications

David K Choi